Epidemiology from Literature | Cohort | Year | Country | Test | Subjects | Positive (%) | Bibliography | 1.10 - Any allergy symptom, Diagnosed | 2010 | Belgium | IgE | 86 | 12.790 | 20101214, Gadisseur R
| 1.10 - Any allergy symptom, Diagnosed | 2010 | Italy | IgE | 16408 | 2.450 | 20100301, Scala E
| 1.10 - Any allergy symptom, Diagnosed | 2011 | Spain | IgE | 1018 | 13.550 | 20111011, Vidal C
| 1.2.1 - Asthma, Diagnosed (Adults) | 2012 | Sweden | IgE | 96 | 1.040 | 20120528, Patelis A
| 1.3 - Rhinitis, Diagnosed | 2013 | Brazil | IgE | 101 | 1.900 | 20130912, Lacerda Araujo LM
| 1.4 - Respiratory Symptoms, Diagnosed | 2002 | Italy | IgE | 1831 | 23.000 | 2002, Mari A
| 1.5 - Atopic Dermatitis, Diagnosed | 2013 | Germany | IgE | 140 | 5.000 | 20130111, Ott H
| 1.5 - Atopic Dermatitis, Diagnosed | 2009 | Germany | IgE | 20 | 15.000 | 20091005, Ott H
| 1.8 - Fruit Allergy | 2012 | Spain | IgE | 212 | 10.000 | 20120912, Palacin A
| 1.9 - Pollen Allergy | 2012 | Spain | IgE | 117 | 5.000 | 20120912, Palacin A
| 10.1 - Normal Control | 2012 | Belgium | IgE | 27 | 0.000 | 20110223, De Knop KJ
| 10.1 - Normal Control | 2009 | Belgium | IgE | 26 | 0.000 | 20091121, Ebo DG
| 4.1.2 - Heterologous Source Sensitized (Symptoms, SPT) | 2011 | China | IgE | 100 | 0.000 | 20111214, Zheng YW
| 4.1.2 - Heterologous Source Sensitized (Symptoms, SPT) | 2010 | Spain | IgE | 31 | 29.030 | 20100812, Palacin A
| 4.1.3 - Heterologous Source Sensitized (SPT) | 1999 | Italy | IgE | 326 | 41.700 | 1999, Mari A
| 4.1.3 - Heterologous Source Sensitized (SPT) | 2001 | Italy | SPT | 548 | 43.900 | 2001, Mari A
| 4.1.4 - Heterologous Source Sensitized (Symptoms, IgE) | 2009 | Belgium | IgE | 22 | 4.550 | 20091121, Ebo DG
| 4.1.4 - Heterologous Source Sensitized (Symptoms, IgE) | 2009 | France | IgE | 41 | 41.460 | 20090108, Guilloux L
| 4.1.5 - Heterologous Source Sensitized (IgE) | 2009 | Belgium | BPT | 20 | 10.000 | 20091121, Ebo DG
| 4.1.5 - Heterologous Source Sensitized (IgE) | 2010 | Sweden | IgE | 150 | 8.660 | 20100212, Asarnoj A
| 4.1.7 - Heterologous Source Sensitized (Symptoms, SPT, IgE) | 2009 | Belgium | IgE | 37 | 5.405 | 20090826, Ebo DG
| 4.1.7 - Heterologous Source Sensitized (Symptoms, SPT, IgE) | 2004 | Belgium | IgE | 24 | 20.800 | 20040116, Ebo D
| 4.1.7 - Heterologous Source Sensitized (Symptoms, SPT, IgE) | 2009 | Denmark | IgE | 21 | 29.000 | 20090406, Skamstrup Hansen K
| 4.1.7 - Heterologous Source Sensitized (Symptoms, SPT, IgE) | 2009 | Denmark | IgE | 20 | 40.000 | 20090406, Skamstrup Hansen K
| 4.1.7 - Heterologous Source Sensitized (Symptoms, SPT, IgE) | 2012 | France | IgE | 97 | 7.210 | 20120706, Garnier L
| 4.1.7 - Heterologous Source Sensitized (Symptoms, SPT, IgE) | 2011 | Germany | IgE | 65 | 72.300 | 20110401, Mertens M
| 4.1.7 - Heterologous Source Sensitized (Symptoms, SPT, IgE) | 2011 | Germany | IgE | 65 | 47.690 | 20110401, Mertens M
| 4.1.7 - Heterologous Source Sensitized (Symptoms, SPT, IgE) | 2011 | Germany | IgE | 22 | 0.000 | 20110401, Mertens M
| 4.1.7 - Heterologous Source Sensitized (Symptoms, SPT, IgE) | 2011 | Germany | IgE | 22 | 0.000 | 20110401, Mertens M
| 4.1.7 - Heterologous Source Sensitized (Symptoms, SPT, IgE) | 2013 | Italy | IgE | 36 | 0.000 | 20130420, Palazzo P
| 4.1.7 - Heterologous Source Sensitized (Symptoms, SPT, IgE) | 2014 | Spain | IgE | 130 | 33.800 | 20140401, Armentia A
| 4.1.7 - Heterologous Source Sensitized (Symptoms, SPT, IgE) | 2012 | Spain | IgE | 55 | 1.800 | 20120726, Pedrosa M
| 4.1.7 - Heterologous Source Sensitized (Symptoms, SPT, IgE) | 2009 | Spain | IgE | 20 | 75.000 | 20090406, Skamstrup Hansen K
| 4.1.7 - Heterologous Source Sensitized (Symptoms, SPT, IgE) | 2009 | Spain | IgE | 17 | 71.000 | 20090406, Skamstrup Hansen K
| 4.1.7 - Heterologous Source Sensitized (Symptoms, SPT, IgE) | 2009 | Switzerland | IgE | 21 | 57.000 | 20090406, Skamstrup Hansen K
| 4.1.7 - Heterologous Source Sensitized (Symptoms, SPT, IgE) | 2009 | Switzerland | IgE | 20 | 45.000 | 20090406, Skamstrup Hansen K
| 4.1.7 - Heterologous Source Sensitized (Symptoms, SPT, IgE) | 2008 | Switzerland | IgE | 99 | 29.290 | 20081218, Muller UR
| 4.1.7 - Heterologous Source Sensitized (Symptoms, SPT, IgE) | 2008 | Switzerland | IgE | 99 | 12.120 | 20081218, Muller UR
| 4.1.8 - Heterologous Source Sensitized (SPT, IgE) | 2012 | Spain | IgE | 68 | 0.000 | 20120726, Pedrosa M
| 5.3.1 - Source Exposed (Symptoms, IgE) | 2012 | Belgium | IgE | 99 | 4.040 | 20110223, De Knop KJ
| 6.2 - General Population (Adults) | 2012 | Sweden | IgE | 371 | 0.000 | 20120528, Patelis A
|
|